-
Windtree Therapeutics Inc (OTC: WINT) shares dipped
67.7 percent to $0.275 after the company disclosed top line results for its AEROSURF® phase 2b clinical trial for the treatment
of respiratory distress syndrome in premature infants. The company announced that AEROSURF trial did not meet the primary
endpoint. Stifel Nicolaus downgraded Windtree Therapeutics from Buy to Hold.
-
Destination Maternity Corp (NASDAQ: DEST) shares
declined 32.2 percent to $3.16 after rising 2.18 percent on Thursday.
-
Cara Therapeutics Inc (NASDAQ: CARA) shares
tumbled 31.1 percent to $17.58 after the company released concerning top-line results from a phase 2B trial of its oral CR845
therapy for the treatment of pain associated with osteoarthritis of the hip or knee. Janney Capital downgraded Cara
Therapeutics from Buy to Neutral.
-
NXT-ID Inc (NASDAQ: NXTD) shares fell 25.4
percent to $2.14.
-
Moleculin Biotech Inc (NASDAQ: MBRX) shares
dropped 25.3 percent to $2.22 after declining 9.45 percent on Thursday.
-
Spherix Inc (NASDAQ: SPEX) shares dipped 25.3
percent to $2.93 after surging 105.24 percent on Thursday.
-
MoSys Inc. (NASDAQ: MOSY) shares dipped 20.7
percent to $1.84. MoSys priced 1.325 million shares at $1.70 per share.
-
Cinedigm Corp (NASDAQ: CIDM) shares fell 10.3
percent to $1.83. Cinedigm reported 'significant' strategic investment from Bison Capital. The company entered into a stock
purchase agreement to sell Bison 20 million shares for $30 million. Cinedigm also posted Q4 consolidated adjusted EBITDA of
$6.7 million, and consolidated revenue of $19.6 million.
-
Exfo Inc (NASDAQ: EXFO) dropped 9 percent to $
4.55 as the company posted downbeat results for its third quarter and issued a weak forecast for the current quarter.
-
California Resources Corp (NYSE: CRC) declined 8.6
percent to $8.57. Bank of America downgraded California Resources from Neutral to Underperform.
-
American Outdoor Brands Corp (NASDAQ: AOBC)
shares dropped 7.1 percent to $22.25. American Outdoor Brands reported better-than-expected results for its fourth quarter, but
issued a weak outlook for fiscal 2018.
-
Sturm Ruger & Company Inc (NYSE: RGR) fell 7 percent
to $ 62.70. Sturm, Ruger & Company reported the promotion of Thomas P. Sullivan to Senior Vice President of Operations.
-
Vipshop Holdings Ltd - ADR (NYSE: VIPS) declined
6.8 percent to $10.74. Deutsche Bank downgraded Vipshop from Buy to Hold.
-
Re/Max Holdings Inc (NYSE: RMAX) dropped 4.4
percent to $55.20. Bank of America downgraded Re/Max from Neutral to Underperform.
-
Micron Technology, Inc. (NASDAQ: MU) slipped 4
percent to $30.20. Micron reported upbeat results for its third quarter and issued a strong forecast for the current quarter.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.